The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 10, 2006, Pages 1075-1081

  Crandall, Jill ^a   Schade, David ^a   Ma, Yong ^a   Fujimoto, Wilfred Y ^a   Barrett Connor, Elizabeth ^a   Fowler, Sarah ^a   Dagogo Jack, Sam ^a   Andres, Reubin ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; PLACEBO;

ADULT; AGED; AGING; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; FOOD INTAKE; GASTROINTESTINAL TOXICITY; GLUCOSE METABOLISM; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK; SIDE EFFECT; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 33750918489     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.10.1075     Document Type: Article

References (40)

1. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
2. Harris M, Flegal K, Cowie C, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey. Diabetes Care. 1998;21:518-524.
3. Resnick H, Harris M, Brock D, Harris T. American Diabetes Association diabetes diagnostic-criteria, advancing age and cardiovascular disease risk profiles. Diabetes Care. 2000;23:176-180.
4. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. Diabetes Care. 1998;21:1236-1239.
5. Balkau B. New diagnostic criteria for diabetes and mortality in older adults. Lancet. 1999;353:68-69.
6. Wahl P, Savage P, Psaty B, et al. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet. 1998;352:1012-1015.
7. The DECODE Study Group. Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care. 1999;22:1667-1671.
8. Shaw JE, Hodge AM, deCourten M, Chitson P, Zimmet P. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia. 1999;42:1050-1054.
9. The DPP Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effect of lifestyle intervention and metformin. Diabetes. 2005;54:2402-2414.
10. The DPP Research Group. The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623-634.
11. The DPP Research Group. The Diabetes Prevention Program: description of lifestyle intervention. Diabetes Care. 2002;25:2165-2171.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report on the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
13. World Health Organization: Diabetes Mellitus: report of a WHO study group. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series No. 727.
14. Kriska AM, Caspersen CJ. Introduction to a collection of physical activity questionnaires. Med Sci Sports Exerc. 1997;29(suppl):S5-S9.
15. Mayer-Davis EJ, Vitolins MZ, Carmichael SL, et al. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology study. Ann Epidemiol. 1999;9:314-324.
16. Lehmann EL. Nonparametric Statistical Methods Based on Ranks. New York: McGraw-Hill; 1975.
17. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. Sas System for Mixed Models. Cary, NC: SAS Institute Inc.; 1996
18. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York, Oxford University Press; 1994.
19. Cox DR. Regression models and life tables. J R Stat Soc. Series B. 1972;34:187-220.
20. Holm S. A simple sequentially rejective Bonferroni test procedure. Scandinavian J Statistics. 1979;6:65-70.
21. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs. 2003;63:1879-1894.
22. Meigs J, Muller D, Nathan D, Blake D, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes. 2003;52:1475-1484.
23. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
24. Pan XR, Li GW, Hu YU, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
25. Chaisson J, Josse R, Gomis R, et al. for the STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet. 2002;359:2072-2077.
26. Buchanan TA, Xiang AH, Peters RJK, et al. Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacologic treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803.
27. Basu R, Breda E, Oberg A, et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes. 2003;52:1738-1748.
28. Chen M, Bergman R, Pacini G, Port D. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta cell function. J Clin Endocrinol Metab. 1985;60:13-20.
29. Utzschneider K, Carr D, Hull R, et al. Impact of intra-abdominal fat and age on insulin sensitivity and β-cell function. Diabetes. 2004;53:2867-2872.
30. Utzschneider KM, Carr DB, Barness SM, Kahn SE, Schwartz RS. Diet-induced weight loss is associated with an improvement in beta-cell function in older men. J Clin Endocrinol Metab. 2004;89:2704-2710.
31. Williams KV, Kelley DE. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes. Diabetes Obes Metab. 2000;2:121-129.
32. Holten M, Zacho M, Gaster M, et al. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes. 2004;53:294-305.
33. Dunstan D, Daly R, Owen N, et al. High intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care. 2002;25:1729-1736.
34. Castaneda C, Layne J, Munoz-Orians L, et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care. 2002;25:2335-2341.
35. Miller J, Pratley R, Goldberg A, et al. Strength training increases insulin action in healthy 50-65 year old men. J Appl Physiol. 1994;77:1122-1127.
36. Kahn S, Larson V, Beard J, et al. Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol. 1990;258:E937-E943.
37. Cox J, Cortright R, Dohm GL, Houmard J. Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity. J Appl Physiol. 1999;86:2019-2025.
38. Short K, Vittone J, Bigelow M, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003;52:1888-1896.
39. Meneilly G, Elliott T. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care. 1999;22:112-118.
40. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes. 1996;45:947-953.